Otitis Media Clinical Trial
Official title:
Thorough Clinical Investigation of the Host-pathogen Interaction in Chronic and Recurrent Otitis Media
Otitis Media (OM) is one of the most frequent diseases in childhood and the primary reason
for children to visit a physician. In many countries it is the most common reason to
prescribe antibiotics leading to increased drug-resistance of the causative agents, or to
undergo surgery. Costs for general health care are expanding, and are estimated to be 3-5
billion dollar annually in the United States. Prevention is suspected to be an important
solution to this problem.
Although OM management has no universal standard yet, it may imply watchful waiting,
antibiotic treatment, adenoidectomy, insertion of tympanostomy tubes and (future)
vaccination. Approximately 80% of the acute otitis media (AOM) cases is self-limiting within
2-14 days and also otitis media with effusion (OME) resolves spontaneously: 60% of newly
detected OME resolves within 3 months. However, in a significant part of the OM population
persistent or recurrent episodes of OM are responsible for a significant morbidity for both
children and parents, despite variable treatment options.
Through the set up of a new prospective cohort in a clinical setting, relevant patient
characteristics, the role of bacterial and viral pathogens, the role of recurrent infection
in relation to biofilm formation, and the host response at protein level will be studied in
detail. This project is expected to increase the understanding of the underlying mechanisms
of OM disease, which will support future treatment and prevention strategies. Better
understanding in OM pathogenesis is warranted in order to develop these novel preventive
strategies.
n/a
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04016051 -
Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections
|
Phase 3 | |
| Completed |
NCT02452164 -
Family MobilePhone Otoscopy in Diagnostics of Otitis Media
|
N/A | |
| Completed |
NCT01199016 -
Effect of Prevnar 13 on Ear Infections in Children
|
Phase 4 | |
| Terminated |
NCT00778063 -
Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients
|
N/A | |
| Completed |
NCT00195611 -
Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media
|
Phase 4 | |
| Recruiting |
NCT03722160 -
Clinical Study of the Solo Tympanostomy Tube Device
|
N/A | |
| Recruiting |
NCT04447521 -
Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium
|
||
| Active, not recruiting |
NCT05127161 -
Broad Implementation of Outpatient Stewardship
|
N/A | |
| Completed |
NCT02600559 -
Open-Label Study of OTO-201 in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy Tubes
|
Phase 3 | |
| Completed |
NCT01444391 -
inVENT-visIOn Study
|
N/A | |
| Enrolling by invitation |
NCT01437436 -
The Effect of Obesity on Ventilation Tube Insertion
|
N/A | |
| Completed |
NCT01003210 -
Homeopathic Ear Drops for Otitis Media Study
|
N/A | |
| Completed |
NCT00768534 -
Study Evaluating Microbiological Analysis of Spontaneous Draining Acute Otitis Media
|
N/A | |
| Recruiting |
NCT00393159 -
The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in Children
|
Phase 4 | |
| Completed |
NCT00617682 -
Maternal Immunization To Prevent Infant Otitis Media
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT00956748 -
N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis Media
|
Phase 4 | |
| Withdrawn |
NCT01908764 -
Pharmacokinetic Study of AL-60371 Otic Suspension in Pediatric Subjects Following Tympanostomy Tube Surgery
|
Phase 1 | |
| Recruiting |
NCT01619462 -
Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children
|
Phase 3 | |
| Completed |
NCT02616458 -
The Impact of Ear Pain Anticipatory Guidance Counseling on Otitis Related Visits in a Low Income Population
|
N/A | |
| Completed |
NCT00051753 -
Levofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute Otitis Media
|
Phase 3 |